theacrine
Small moleculeexperimental
Theacrine, also known as 1,3,7,9-tetramethyluric acid, is a purine alkaloid found in cupuaçu and in a Chinese kucha tea. It shows anti-inflammatory and analgesic effects and appears to affect adenosine signalling in a manner similar to caffeine. In kucha leaves, theacrine is synthesized from caffeine in what is thought to be a three-step pathway. Theacrine and caffeine are structurally similar. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 23, 2019 (NCT03937687)
Timeline
2010s
- Jan 1, 2019
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTheacrine ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05170113 | N/A | Nov 2, 2021 | Supplement Formulators, Inc. |
| NCT03937687 | Early Phase 1 (Phase 1) | Apr 23, 2019 | Compound Solutions Inc., Rutgers University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Compound Solutions Inc. | For profit | 1 | 0 | 1 | 2019 |
| Rutgers University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Supplement Formulators, Inc. | For profit | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1